SM
Summit Therapeutics
SMMT·NASDAQCambridge UKFounded 200340 employees
Mid CapbiotechPublicOncologyInfectious Disease
Platform: Ivonescimab PD-1/VEGF
Market Cap
$3B
All Drugs
3
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (SMMT)
Loading SMMT stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Bemaderotide | SMM-4015 | Phase 2/3 | 2 | JAK2 | Ovarian CaUrothelial Ca | ||
| SMM-5951 | SMM-5951 | Phase 2/3 | 1 | LAG-3 | AngelmanRCC | ||
| Tixarelsin | SMM-5507 | Phase 2/3 | 2 | CFTR | EoEMCC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)